Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess changes in ADHD symptoms and tolerability of
medication in children and adolescents switching from a stimulant to atomoxetine.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Atomoxetine Hydrochloride Central Nervous System Stimulants